Literature DB >> 18652127

Value of the intraoperative assessment of the depth of myometrial invasion in endometrial carcinoma.

Bogdan Obrzut1, Marzanna Obrzut, Joanna Skret-Magierło, Andrzej Skret, Dariusz Ulman, Piotr Król, Marcin Zmuda.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the value of intraoperative assessment of depth of myometrial invasion in patients with FIGO stage I of the endometrial carcinoma.
MATERIAL AND METHODS: A total number of 112 patients with FIGO stage I of the endometrial carcinoma undergoing surgery were enrolled in the study. All patients had undergone intraoperative assessment of the depth of myometrial invasion performed by a surgeon. The depth was determined as more or less than 50% of myometrial thickness according to FIGO classification. Gross visual estimation of the depth of myometrial invasion at the time of the operation was compared with the final histopathological report. Sensitivity, specificity and positive and negative predictive values of the method were determined by means of statistical analyses.
RESULTS: The depth of the myometrial invasion was accurately determined by the surgeon in 82.1% of cases. Sensitivity and specificity were 68% and 82.1%, respectively. The accurate prediction rate of the myometrial invasion in the group of patients with well differentiated (G1) endometrial carcinoma was higher (88.4%) than in group with moderately and low differentiated tumour (78.3%).
CONCLUSIONS: The accuracy of macroscopic evaluation of myometrial invasion is high and reaches up to 82.1%. The accurate determination rate increases if the differentiation of tumour is higher.

Entities:  

Mesh:

Year:  2008        PMID: 18652127

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  1 in total

1.  The guidance of intraoperative frozen section for staging surgery in endometrial carcinoma: frozen section in endometrial carcinoma.

Authors:  Arbil Acikalin; Derya Gumurdulu; Emine Kilic Bagir; Goncagül Torun; Ahmet Baris Guzel; Handan Zeren; Mehmet Ali Vardar
Journal:  Pathol Oncol Res       Date:  2014-05-20       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.